Study adds to efforts to find more effective anti-inflammatory drugs

September 27, 2012 in Inflammatory disorders

Researchers have discovered a previously unknown function for a protein that could add to the expanding arsenal of potential new drugs for battling inflammation and tissue fibrosis in a number of disease processes.

Scientists from Cincinnati Children's Hospital Medical Center report Sept. 27 in Developmental Cell that, a protein called TRPC6 mediates a molecular pathway critical to the body's repair processes following various forms of injury caused by disease.

After injury – such as that caused by a heart attack – the TRPC6-controlled pathway prompts cells called fibroblasts to change into myofibroblasts, according to the study.

Myofibroblasts secrete a substance called extracellular matrix, an important building block needed for wound healing and tissue remodeling, which includes inflammation and scarring.

"Our study suggests that a TRPC inhibitor could be a good anti-fibrotic or anti- in , muscular dystrophy, and other diseases where becomes a problem," said Jeffery Molkentin, PhD, principal investigator and a scientist at the Cincinnati Children's Heart Institute and Howard Hughes Medical Institute. "As well, activation of the TRPC pathway with an agonist compound could be used in select situations to enhance wound healing."

Although the body needs a certain amount of inflammation and scarring to heal and return to normal function, in the process can get stuck in the "on" mode. This can lead to fibrosis (the buildup of excess connective tissues) and cause serious . Effectively and safely controlling complex inflammation processes in these situations remains an unmet clinical need, and is also the impetus behind a concerted effort in biomedical research to find new .

Researchers on the current study were encouraged by how effectively the TRPC6 pathway (TRPC6-calcineurin-NFAT) appeared to influence the transformation of fibroblasts into myofibroblasts, the secretion of extracellular matrix, wound healing and fibrosis. The authors wrote that identification of this cell repair signaling mechanism "offers an additional avenue for developing targeted intervention points in fibrotic diseases."

Calcineurin is a calcium-dependent enzyme involved in the immune system, the regulation of T-cells and also important in the function of heart cells. NFAT (nuclear factor of activated T-cells) is a family of proteins important to the immune system and the development of different tissues in the body.

Including first author Jennifer Davis, PhD. – a member of Molkentin's laboratory – the researchers started their study by running a genomic screen of molecules that regulate the transformation of fibroblast cells into myofibroblasts. The screen and subsequent laboratory tests identified TRPC6 as a promising candidate. Prior to the current study, TRPC6 had not been associated with fibrosis, although it has been linked to other cellular functions in kidneys, skin cells and hippocampal neurons of the brain.

The scientists used a virus expressing TRPC6 to infect cell cultures of mouse embryonic fibroblasts, rat cardiac fibroblasts and human dermal fibroblasts. TRPC6-infected fibroblasts fully activated the transformation to myofibroblasts, while fibroblasts lacking TRPC6 were resistant to transformation. In TRPC-6 gene deleted mice, the animals showed impaired dermal and cardiac wound healing after injury.

Molkentin said there are TRPC inhibitors in the early stage drug development pipeline, although their initial design has not targeted heart disease, inflammation or fibrosis. He added the current study may provide an impetus for widening the development focus to include these medical needs.

Journal reference: Developmental Cell search and more info website

Provided by Cincinnati Children's Hospital Medical Center search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Asthma symptoms impair sleep quality and school performance in children

The negative effects of poorly controlled asthma symptoms on sleep quality and academic performance in urban schoolchildren has been confirmed in a new study.

Inflammatory disorders created 12 hours ago | popularity not rated yet | comments 0

Inflammatory bowel disease raises risk of melanoma

Patients with inflammatory bowel disease (IBD) are at higher risk of melanoma, a form of skin cancer, report researchers at Mayo Clinic. Researchers found that IBD is associated with a 37 percent greater risk for the disease. ...

Inflammatory disorders created May 20, 2013 | popularity 4 / 5 (1) | comments 0

New research reveals swimming beneficial for young people with asthma

New research by medical students working in the Breathe Well Centre of Research Excellence at the UTAS School of Medicine has revealed swimming has health benefits for young people with asthma, with no adverse effects on ...

Inflammatory disorders created May 10, 2013 | popularity not rated yet | comments 0

Nearly 5 million asthmatics could benefit from antifungal therapy

An estimated 4,837,000 asthmatics with allergic bronchopulmonary aspergillosis (ABPA) could benefit substantially from antifungal treatment, say researchers from The University of Manchester and the University of Toronto.

Inflammatory disorders created May 08, 2013 | popularity not rated yet | comments 0

Type 1 diabetes and heart disease linked by inflammatory protein

Type 1 (insulin-dependent) diabetes appears to increase the risk of heart disease, the leading cause of death among people with high blood sugar, partly by stimulating the production of calprotectin, a protein that sparks ...

Inflammatory disorders created May 07, 2013 | popularity 4.5 / 5 (2) | comments 0 | with audio podcast


If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

Antidepressant reduces stress-induced heart condition

A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.